Jozefien Declercq

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Chitin Is a Potent Inducer of Type 2 Airway Inflammation Independent of Endogenous Chitinolytic Activity.

Chitin Is a Potent Inducer of Type 2 Airway Inflammation Independent of Endogenous Chitinolytic Activity.

Journal: Allergy

Published: July 03, 2025

Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa.

Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa.

Journal: Science translational medicine

Published: October 23, 2024

Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.

Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.

Journal: Scientific reports

Published: September 07, 2023

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

Journal: Science translational medicine

Published: August 23, 2023

Chitinases and chitinase-like proteins in asthma.

Chitinases and chitinase-like proteins in asthma.

Journal: Seminars in immunology

Published: March 06, 2023

RNA viruses alter house dust mite physiology and allergen production with no detected consequences for allergenicity.

RNA viruses alter house dust mite physiology and allergen production with no detected consequences for allergenicity.

Journal: Insect molecular biology

Published: October 03, 2022

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.

Journal: Respiratory research

Published: April 29, 2022

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment.

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment.

Journal: Cell reports. Medicine

Published: April 14, 2022

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.

Journal: Cytokine

Published: December 22, 2021

Granulocyte-colony stimulating factor: Missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients.

Granulocyte-colony stimulating factor: Missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients.

Journal: The Journal of allergy and clinical immunology

Published: August 24, 2021

COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies.

COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies.

Journal: Allergy

Published: July 13, 2021

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

Journal: The Journal of experimental medicine

Published: June 28, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026